Journal article

Cerebrospinal fluid levels of amyloid precursor protein and amyloid β-peptide in Alzheimer's disease and major depression - Inverse correlation with dementia severity

C Hock, S Golombowski, F Müller-Spahn, W Naser, K Beyreuther, U Mönning, D Schenk, C Vigo-Pelfrey, AI Bush, R Moir, RE Tanzi, JH Growdon, RM Nitsch

European Neurology | KARGER | Published : 1998

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disorder characterized by progressive dementia that ultimately leads to death. Histopathological hallmarks of AD include brain amyloid deposits and neurofibrillary tangles. Major depression is a frequent diagnosis in every gerontopsychiatric clinic that sees patients with both cognitive and affective disorders. Many depressed patients, in fact, are clinically characterized by cognitive impairments. Thus, an assay that excludes - or confirms - probable AD in cognitively impaired patients is desirable. Such assays may use protein markers that are derived from such histopathologically relevant molecules as the amyloid precursor prote..

View full abstract

University of Melbourne Researchers